glp 1 hospitalization Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease Results of cardiovascular outcomes trials

A selective enzymatic inhibitor of 15LO1, BLX2477 (gift from Hans-Erik Claesson, Karolinska Institutet, Stockholm, Sweden

The resulting catastrophic energy deficit is a primary physiological driver of post-exertional malaise (PEM) or 'crashes,' where even minor, everyday activities trigger a disproportionate and prolonged exacerbation of profound fatigue, muscle weakness, and cognitive impairment

Yadav S, Ramesh K, Reddy OS et al (2023) Redox-responsive comparison of diselenide and disulfide core-cross-linked micelles for drug delivery application

If you stop using glutathione injections, your skin is likely to return to its natural tone over time

Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, et al